KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Palvella Therapeutics, Inc. (PVLA) Tax Provisions (2017 - 2018)

Palvella Therapeutics (PVLA) has disclosed Tax Provisions for 4 consecutive years, with -$164000.0 as the latest value for Q4 2018.

  • On a quarterly basis, Tax Provisions fell 214.21% to -$164000.0 in Q4 2018 year-over-year; TTM through Sep 2019 was -$164000.0, a 3622.2% decrease, with the full-year FY2020 number at $164000.0, changed N/A from a year prior.
  • Tax Provisions was -$164000.0 for Q4 2018 at Palvella Therapeutics, down from -$148000.0 in the prior quarter.
  • In the past five years, Tax Provisions ranged from a high of $814000.0 in Q2 2017 to a low of -$164000.0 in Q4 2018.
  • A 4-year average of $110602.7 and a median of $40441.0 in 2015 define the central range for Tax Provisions.
  • Biggest YoY gain for Tax Provisions was 118.18% in 2018; the steepest drop was 214.21% in 2018.
  • Palvella Therapeutics' Tax Provisions stood at -$18.0 in 2014, then skyrocketed by 908016.67% to $163425.0 in 2015, then dropped by 12.13% to $143594.0 in 2017, then crashed by 214.21% to -$164000.0 in 2018.
  • Per Business Quant, the three most recent readings for PVLA's Tax Provisions are -$164000.0 (Q4 2018), -$148000.0 (Q2 2018), and $143594.0 (Q4 2017).